Yohimbe
Overview
Yohimbe is the name of an evergreen tree found in parts of central and western Africa. The bark of yohimbe contains a chemical called yohimbine, which is used to make medicine. Yohimbine hydrochloride (Aphrodyne, Yocon) is a form of yohimbine that is a prescription drug in the US.
Yohimbe supplements often list yohimbe bark extract or yohimbine as the active ingredient. However, some of these products might not provide accurate information about the amount of yohimbine in the supplement. Also, some yohimbe supplements list yohimbine hydrochloride as an active ingredient. Yohimbe products containing man-made yohimbine hydrochloride as an ingredient are not legal to sell as a dietary supplement in the US.
Yohimbe is taken by mouth arouse sexual excitement, for erectile dysfunction (ED), sexual problems caused by medications for depression called selective-serotonin reuptake inhibitors (SSRIs), and general sexual problems in both men and women. It is also used for athletic performance, weight loss, exhaustion, chest pain, high blood pressure, low blood pressure that occurs when standing up, diabetic nerve pain, and for depression along with certain other medications.
Classification
Is a Form of:
Tree
Primary Functions:
Erectile dysfunction
Also Known As:
Yohimbehe, Yohimbehe Cortex, Yohimbine
How Does It Work?
Yohimbe contains a chemical called yohimbine which can increase blood flow and nerve impulses to the penis or vagina. It also helps counteract the sexual side effects of certain medications used for depression.
Uses
- Anxiety. There is mixed evidence about the effectiveness of yohimbine, the active ingredient in yohimbe, for treating anxiety related to phobias. Some research suggests that it does not improve anxiety when combined with therapy. However, other research suggests that it reduces fear related to certain phobias.
- Depression. Early research suggests that taking yohimbine, the active ingredient of yohimbe, daily for 10 days does not improve depression symptoms.
- Erectile dysfunction (ED). There is evidence that yohimbine, the active ingredient of yohimbe, can be helpful for ED. Some herbalists suggest that the yohimbe bark actually works better than the yohimbine ingredient alone. However, so far yohimbe bark has not been evaluated in research studies.
- Exercise performance. Early research suggests that taking yohimbine, the active ingredient in yohimbe, daily for 21 days does not improve exercise performance or build muscle mass in soccer players.
- Head rush (orthostatic hypotension). Early research suggests that taking a single dose of yohimbine, the active ingredient in yohimbe, increases blood pressure in people with a head rush due to low blood pressure. However, other early research suggests that it does not improve blood pressure.
- Sexual problems caused by selective-serotonin reuptake inhibitors (SSRIs). There is evidence from many studies that yohimbine, the active ingredient of yohimbe, can improve sexual problems associated with this class of medications used for depression. However, this benefit has not been described specifically for the yohimbe bark.
- Dry mouth. Early research suggests that taking yohimbine, the active ingredient in yohimbe, improves symptoms of dry mouth in people taking antidepressants. The effect of the yohimbe bark on dry mouth is not clear.
- Exhaustion.
- Chest pain.
- Diabetic complications.
- Other conditions.
Recommended Dosing
The following doses have been studied in scientific research:
BY MOUTH:
- For problems with sexual performance: 15-30 mg daily of yohimbine, the active ingredient in yohimbe. Doses of up to 100 mg of yohimbine daily have been used. However, significant side effects, some quite dangerous (including the possibility of death), would be expected with such a high dose.
Yohimbe Supplements Frequently Asked Questions
What are the benefits of yohimbe?
Benefits of Yohimbe
Because of the effect it has on the sympathetic nervous system, Yohimbe helps to improve blood flow and circulation throughout the body (this is why some people also use it to help treat erectile dysfunction). Yohimbine can act as a vasodilator (meaning it causes the blood cells to expand).
Is it safe to take yohimbe everyday?
Doses of up to 100 mg of yohimbine daily have been used. However, significant side effects, some quite dangerous (including the possibility of death), would be expected with such a high dose.
Why is yohimbine banned?
The FDA removed yohimbine from prescription status in mid-90s because of its potential for harm, he said. But it was never banned in the United States, and “it has found its way back onto the market in herbal supplements and dietary aides,” Berman said.
When should I take Yohimbe?
Take Between Meals and Before a Workout
Yohimbe appears to be most effective when it's consumed while in a fasted state. It also yields the best results when it's paired with consistent exercise (which is why it's included in many pre-workout supplements).
How quickly does yohimbe work?
Suffice to say this is like a crude Viagra: kicks in at about 20 mins and lasts for the purpose most would use it for for about an hour. But the elevated pulse and body heat (sweating) and adrenaline rush go on for about 3 hours.
Does yohimbe boost testosterone?
Yohimbine is a herbal preparation from the bark of the Pausinystalia and Corynanthe yohimbe trees that purportedly enhances plasma testosterone levels and promotes skeletal muscle hypertrophy, sexual vigor, and decreased body fat (Galitzky, Taouis, Berlan et al.
Does yohimbe help erectile dysfunction?
Yohimbe is a popular herbal supplement marketed to help with erectile dysfunction and improve body composition and weight loss. Yohimbine is the main active ingredient in yohimbe supplements, and there is evidence that it can effectively improve erectile dysfunction.
How long does yohimbe last?
Yohimbine. Yohimbine is found in a variety of botanical sources and is the principal alkaloid extracted from the bark of the Pausinystalia yohimbe tree. It is rapidly absorbed after oral administration with a peak plasma concentration occurring at 30 minutes and a half-life of 5 hours [2].
Can yohimbe cause heart attack?
Yohimbe has been linked to reports of severe side effects including irregular or rapid heart beat, kidney failure, seizure, heart attack, and others. Taking high doses can also cause other severe problems, including difficulty breathing, paralysis, very low blood pressure, heart problems, and death.
Does Yohimbine burn fat?
Yohimbe, especially when it's combined with other stimulating ingredients, can also increase one's heart rate. This, in turn, helps the body to burn more calories both at work and at rest. As a result, you may lose more weight and more body fat when using a supplement that contains Yohimbe.
Does yohimbe increase dopamine?
Effect of yohimbine on brain monoamines: an in vivo study. Dopamine (DA) was not detected in ventricular fluid either before or after yohimbine administration. Yohimbine administration did, however, increase intracellular DA levels in the corpus striatum.
How much yohimbe should I take for Ed?
There are no standard dosing guidelines for yohimbe supplements. Some sources have suggested taking no more than the equivalent of 30 mg of yohimbine hydrochloride per day, or around 10 mg three times daily (10). Other studies have used 0.09 mg/pound/day (0.20 mg/kg/day) in study participants.
Can yohimbe be taken at night?
Yohimbe appears to be most effective when it's consumed while in a fasted state. If you workout in the afternoon or evening, you can still see benefits from taking a supplement that contains Yohimbe.
Can females take Yohimbe?
Given its serious risks, yohimbe should not be used by children or by women who are pregnant or breastfeeding.
Does yohimbe give you energy?
Increased energy levels can help you push yourself farther during workouts (especially when Yohimbe is combined with other stimulants like caffeine).
Can yohimbe cause erectile dysfunction?
Therefore, yohimbine is thought to help alleviate erectile dysfunction by blocking the receptors responsible for preventing erections. Yohimbine may also promote the release of nitric oxide. This could lead to the dilation of blood vessels and an increase in blood flow to sexual organs.
Can I take yohimbine with caffeine?
Many athletes like to use a combination of Yohimbe and caffeine before their morning fasted cardio. You could also take it later in the day, but you should make sure you've had plenty of time to digest your food beforehand.
How do you take Yohimbe?
Take Between Meals and Before a Workout
Yohimbe appears to be most effective when it's consumed while in a fasted state. It also yields the best results when it's paired with consistent exercise (which is why it's included in many pre-workout supplements).
How long after taking Yohimbine can I eat?
If you are going to eat take 1-2 30min BEFORE your meal. Or take 20-30 min before a gym work out. You need to eat better and work out to lose weight, but these help!
Does yohimbe have side effects?
Common side effects of Yohimbine include: Anxiety. Irritability. Headache.
Can yohimbe cause depression?
Depression: Don't use yohimbe. Yohimbine might bring out manic-like symptoms in people with bipolar depression or suicidal tendencies in individuals with depression. Diabetes: Don't use yohimbe. Yohimbe might interfere with insulin and other medications used for diabetes and cause low blood sugar.
What foods contain yohimbe?
There are no natural food sources of yohimbe. The bark extract is sometimes used to make a tea.
Clinical Studies
- ^ Effect of the dietary supplement Meltdown on catecholamine secretion, markers of lipolysis, and metabolic rate in men and women: a randomized, placebo controlled, cross-over study.
- ^ Singh DK, Srivastava B, Sahu A. Spectrophotometric determination of Rauwolfia alkaloids: estimation of reserpine in pharmaceuticals. Anal Sci. (2004)
- ^ a b Cimolai N, Cimolai T. Yohimbine use for physical enhancement and its potential toxicity. J Diet Suppl. (2011)
- ^ Rockhold RW, Gross F. Yohimbine diastereoisomers: cardiovascular effects after central and peripheral application in the rat. Naunyn Schmiedebergs Arch Pharmacol. (1981)
- ^ Weitzell R, Tanaka T, Starke K. Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn Schmiedebergs Arch Pharmacol. (1979)
- ^ Material Safety Data Sheet for Yohimbine hydrochloride.
- ^ Asker AF, Helal MA, Motawi MM. Light stability of some parenteral solutions of reserpine. Pharmazie. (1971)
- ^ Jamil N, et al. Studies on the photostability of reserpine in parenteral solutions. Pharmazie. (1983)
- ^ Strobl GR, et al. Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. J Med Chem. (1993)
- ^ a b c Le Corre P, et al. Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism. Clin Pharmacol Ther. (2004)
- ^ Bharucha AE, et al. Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects. Neurogastroenterol Motil. (2008)
- ^ Ozawa S, et al. Ethnic differences in genetic polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB1. Drug Metab Pharmacokinet. (2004)
- ^ Taouis M, et al. Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog. J Pharmacol Exp Ther. (1988)
- ^ Szemeredi K, et al. Simultaneous measurement of plasma and brain extracellular fluid concentrations of catechols after yohimbine administration in rats. Brain Res. (1991)
- ^ Ehlert U, et al. Salivary alpha-amylase levels after yohimbine challenge in healthy men. J Clin Endocrinol Metab. (2006)
- ^ a b c Meyerbroeker K, et al. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial. Psychother Psychosom. (2012)
- ^ Hedner T, et al. Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers. Eur J Clin Pharmacol. (1992)
- ^ Grossman E, et al. Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients. J Cardiovasc Pharmacol. (1993)
- ^ a b c Galitzky J, et al. Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers. Eur J Clin Pharmacol. (1990)
- ^ a b c Berlan M, et al. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women. Int J Obes. (1991)
- ^ Sturgill MG, et al. Yohimbine elimination in normal volunteers is characterized by both one- and two-compartment behavior. J Cardiovasc Pharmacol. (1997)
- ^ a b Mizuki Y, et al. Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety. Prog Neuropsychopharmacol Biol Psychiatry. (1996)
- ^ Kennedy SH, et al. Melatonin responses to clonidine and yohimbine challenges. J Psychiatry Neurosci. (1995)
- ^ Arnsten AF. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs. (2009)
- ^ Swanson CJ, et al. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology. (2006)
- ^ a b c d Gronier B. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors. Eur Neuropsychopharmacol. (2011)
- ^ Roychowdhury S, et al. α₂- and β-adrenoceptors involvement in nortriptyline modulation of auditory sustained attention and impulsivity. Psychopharmacology (Berl). (2012)
- ^ a b c Callahan MF, Beales M, Oltmans GA. Yohimbine and rauwolscine reduce food intake of genetically obese (obob) and lean mice. Pharmacol Biochem Behav. (1984)
- ^ Jonderko K, Kucio C. Effect of anti-obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patients. Aliment Pharmacol Ther. (1991)
- ^ Clark JT, Smith ER, Davidson JM. Evidence for the modulation of sexual behavior by alpha-adrenoceptors in male rats. Neuroendocrinology. (1985)
- ^ Koskinen I, et al. Yohimbine and naloxone: effects on male rat sexual behavior. Physiol Behav. (1991)
- ^ Clark JT, Smith ER, Davidson JM. Enhancement of sexual motivation in male rats by yohimbine. Science. (1984)
- ^ Rodríguez-Manzo G, Fernández-Guasti A. Reversal of sexual exhaustion by serotonergic and noradrenergic agents. Behav Brain Res. (1994)
- ^ a b Clark JT, Smith ER, Davidson JM. Testosterone is not required for the enhancement of sexual motivation by yohimbine. Physiol Behav. (1985)
- ^ Travison TG, et al. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab. (2006)
- ^ Guay AT, Jacobson J. Decreased free testosterone and dehydroepiandrosterone-sulfate (DHEA-S) levels in women with decreased libido. J Sex Marital Ther. (2002)
- ^ Crespi F. Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety. J Neurosci Methods. (2009)
- ^ a b c Charney DS, Heninger GR, Redmond DE Jr. Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci. (1983)
- ^ Stine SM, et al. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry. (2002)
- ^ Gurguis GN, Vitton BJ, Uhde TW. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls. Psychiatry Res. (1997)
- ^ a b Sommer M, et al. Psychological and neuroendocrine responses to social stress and to the administration of the alpha-2-receptor antagonist, yohimbine, in highly trained endurance athletes in comparison to untrained healthy controls. Pharmacopsychiatry. (2011)
- ^ Rimmele U, et al. Trained men show lower cortisol, heart rate and psychological responses to psychosocial stress compared with untrained men. Psychoneuroendocrinology. (2007)
- ^ a b Cameron OG, et al. Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humans. Psychosom Med. (2000)
- ^ a b c Powers MB, et al. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation. J Anxiety Disord. (2009)
- ^ Gentili A, et al. Effect of clonidine and yohimbine on sleep in healthy men: a double-blind, randomized, controlled trial. Eur J Clin Pharmacol. (1996)
- ^ Anderson KJ, Revelle W. Impulsivity and time of day: is rate of change in arousal a function of impulsivity. J Pers Soc Psychol. (1994)
- ^ Winstanley CA, Eagle DM, Robbins TW. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev. (2006)
- ^ Brennan AR, Arnsten AF. Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function. Ann N Y Acad Sci. (2008)
- ^ Strawn JR, Geracioti TD Jr. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety. (2008)
- ^ Casada JH, Roache JD. Behavioral inhibition and activation in posttraumatic stress disorder. J Nerv Ment Dis. (2005)
- ^ Swann AC, et al. Acute yohimbine increases laboratory-measured impulsivity in normal subjects. Biol Psychiatry. (2005)
- ^ Sun H, et al. Yohimbine increases impulsivity through activation of cAMP response element binding in the orbitofrontal cortex. Biol Psychiatry. (2010)
- ^ a b c Shamloul R. Natural aphrodisiacs. J Sex Med. (2010)
- ^ Double Blind Trial of Yohimbine Hydrochloride in the Treatment of Erection Inadequacy.
- ^ Morales A, et al. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol. (1987)
- ^ Mann K, et al. Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Arch Sex Behav. (1996)
- ^ Reid K, et al. Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet. (1987)
- ^ Vogt HJ, et al. Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction. Int J Impot Res. (1997)
- ^ Susset JG, et al. Effect of yohimbine hydrochloride on erectile impotence: a double-blind study. J Urol. (1989)
- ^ Rowland DL, Kallan K, Slob AK. Yohimbine, erectile capacity, and sexual response in men. Arch Sex Behav. (1997)
- ^ Kernohan AF, et al. An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects. Br J Clin Pharmacol. (2005)
- ^ Lebret T, et al. Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction. Eur Urol. (2002)
- ^ Carmen GY, Víctor SM. Signalling mechanisms regulating lipolysis. Cell Signal. (2006)
- ^ Liu CY, Boyer JL, Mills SE. Acute effects of beta-adrenergic agonists on porcine adipocyte metabolism in vitro. J Anim Sci. (1989)
- ^ Lafontan M, et al. Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies. Am J Clin Nutr. (1992)
- ^ a b c Doxey JC, et al. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine. Naunyn Schmiedebergs Arch Pharmacol. (1984)
- ^ a b Lalchandani SG, et al. Yohimbine dimers exhibiting selectivity for the human alpha 2C-adrenoceptor subtype. J Pharmacol Exp Ther. (2002)
- ^ MacDonald E, Kobilka BK, Scheinin M. Gene targeting--homing in on alpha 2-adrenoceptor-subtype function. Trends Pharmacol Sci. (1997)
- ^ Tan S, Curtis-Prior PB. Comparative effects of RX 781094, mianserin, yohimbine, rauwolscine and prazosin in reversing clonidine inhibition of MIX-stimulated lipolysis in hamster isolated white fat cells. Pharmacol Res Commun. (1984)
- ^ Reiner S, et al. Differential signaling of the endogenous agonists at the beta2-adrenergic receptor. J Biol Chem. (2010)
- ^ a b Greenway FL, Bray GA, Heber D. Topical fat reduction. Obes Res. (1995)
- ^ a b Greenway FL, Bray GA. Regional fat loss from the thigh in obese women after adrenergic modulation. Clin Ther. (1987)
- ^ Pedersen SB, et al. Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J Clin Endocrinol Metab. (2004)
- ^ Keller U, Weiss M, Stauffacher W. Contribution of alpha- and beta-receptors to ketogenic and lipolytic effects of norepinephrine in humans. Diabetes. (1989)
- ^ a b c d Galitzky J, et al. Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers. Eur J Clin Invest. (1988)
- ^ McCarty MF. Pre-exercise administration of yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysis. Med Hypotheses. (2002)
- ^ Ito K, et al. Adrenoceptor antagonists, but not guanethidine, reduce glucopenia-induced glucagon secretion from perfused rat pancreas. Diabetes Res Clin Pract. (1995)
- ^ Ribes G, et al. Involvement of a central nervous pathway in yohimbine-induced insulin secretion. Eur J Pharmacol. (1989)
- ^ a b Ostojic SM. Yohimbine: the effects on body composition and exercise performance in soccer players. Res Sports Med. (2006)
- ^ Sax L. Yohimbine does not affect fat distribution in men. Int J Obes. (1991)
- ^ Biaggioni I, Robertson RM, Robertson D. Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol. (1994)
- ^ Shibao C, et al. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. (2010)
- ^ a b Sandberg M, et al. The α2-Adrenoceptor Antagonist Yohimbine Normalizes Increased Islet Blood Flow in GK Rats: A Model of Type 2 Diabetes. Horm Metab Res. (2012)
- ^ Adeghate E, Ponery AS, Wahab A. Effect of electrical field stimulation on insulin and glucagon secretion from the pancreas of normal and diabetic rats. Horm Metab Res. (2001)
- ^ a b Guay AT, et al. Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial. Int J Impot Res. (2002)
- ^ Cuneo RC, et al. Effects of alpha-2 adrenoreceptor blockade by yohimbine on the hormonal response to hypoglycaemic stress in normal man. Horm Metab Res. (1989)
- ^ Krystal JH, et al. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. Am J Psychiatry. (1996)
- ^ a b c McDougle CJ, et al. Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine. Psychopharmacology (Berl). (1995)
- ^ Mattila M, Seppala T, Mattila MJ. Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam. Int Clin Psychopharmacol. (1988)
- ^ a b Senbel AM, Mostafa T. Yohimbine enhances the effect of sildenafil on erectile process in rats. Int J Impot Res. (2008)
- ^ Jordan J, Sharma AM. Potential for sibutramine-yohimbine interaction. Lancet. (2003)
- ^ a b Waluga M, et al. Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women. Clin Physiol. (1998)
- ^ Schuckit MA. Subjective responses to alcohol in sons of alcoholics and control subjects. Arch Gen Psychiatry. (1984)
- ^ a b c d Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases. Ann Pharmacother. (2010)
- ^ Linden CH, Vellman WP, Rumack B. Yohimbine: a new street drug. Ann Emerg Med. (1985)
- ^ HOLMBERG G, GERSHON S. Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia. (1961)
- ^ Cohen PA, et al. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Test Anal. (2015)
- ^ Giampreti A, et al. Acute neurotoxicity after yohimbine ingestion by a body builder. Clin Toxicol (Phila). (2009)
- Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol. (1998)
- Umhau JC, et al. Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology. (2011)